Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Astera Labs, Inc. Director's Dealing 2024

Oct 4, 2024

30120_dirs_2024-10-04_23e76ee9-3f7e-4589-9ac7-805cd218ce61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-10-02

Reporting Person: Tate Michael Truett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-02 Common Stock G 1033780 Disposed 293128 Direct
2024-10-02 Common Stock G 1033780 Acquired 1862888 Indirect

Footnotes

F1: On October 2, 2024, the Reporting Person transferred 1,033,780 shares of Common Stock to Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust") for no consideration.

F2: These shares are owned directly by the Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.